Skip to main content
. 2018 Dec 15;12(3):426–431. doi: 10.1016/j.tranon.2018.11.015

Figure 2.

Figure 2

Comparison of mutation profiles between baseline and progression. Columns with red (RAS), orange (ERBB2), golden (EGFR), green (PI3K pathway), blue (ALK, ROS1 and MET), pink (CDKN2A and RB1), purple (TP53) and gray (any genes) indicate the presence of gene alterations. Columns with white indicate wild type. PFS, progression-free survival (months). The number in each box indicates the number of mutations of each gene or pathways.